Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $479.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 3.92% Avg Daily Range (30 D): $0.60 | 6.10% Avg Daily Range (90 D): $0.58 | 5.00% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 2.43M Avg Daily Volume (90 D): 1.6M Trade Size Avg Trade Size (Sh.): 204 Avg Trade Size (Sh.) (30 D): 110 Avg Trade Size (Sh.) (90 D): 95 Institutional Trades Total Inst.Trades: 264 Avg Inst. Trade: $1.4M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.15M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.53M Avg Closing Trade (30 D): $1.12M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 128.15K         News May 16, 2025 @ 10:36 PM CAPR Investors Have Opportunity to Join Capricor T... Source: Business Wire May 9, 2025 @ 2:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A May 9, 2025 @ 2:47 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Oct 17, 2024 @ 10:00 AM Capricor Therapeutics Announces Pricing of Approxi... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.37 $-.53 $-.11 Diluted EPS $-1.37 $-.53 $-.11 Revenue $ 17.36M $ M $ 11.13M Gross Profit $ $ $ Net Income / Loss $ -55.06M $ -24.39M $ -7.12M Operating Income / Loss $ -57.28M $ -24.98M $ -7.7M Cost of Revenue $ $ $ Net Cash Flow $ 22.58M $ 17.51M $ -57.09M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20